Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
American Journal of Hematology
|
September 1, 1994
Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid
S A Limentani, J O Pretell, D Potter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2005
Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer
W J Gradishar, S B Wedam, M Jahanzeb, et al.
Cancer Chemotherapy and Pharmacology
|
October 1, 2013
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I study
Rachel C Jankowitz, Jame Abraham, Antoinette R Tan, et al.
British Journal of Cancer
|
July 27, 2006
Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study
A W Blackstock, F Mornex, C Partensky, et al.
British Journal of Haematology
|
September 12, 2008
Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma
Sundar Jagannath, Bart Barlogie, James R Berenson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 11, 2008
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)
Richard J Gralla, Martin J Edelman, Frank C Detterbeck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study
M Martin, P Fumoleau, J A Dewar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial
Mark A Socinski, David E Morris, Jan S Halle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 2, 2008
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer
Frank C Detterbeck, Mark A Socinski, Richard J Gralla, et al.
British Journal of Haematology
|
October 6, 2004
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
S Jagannath, B Barlogie, J Berenson, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
American Journal of Hematology
|
September 1, 1994
Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid
S A Limentani, J O Pretell, D Potter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2005
Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer
W J Gradishar, S B Wedam, M Jahanzeb, et al.
Cancer Chemotherapy and Pharmacology
|
October 1, 2013
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I study
Rachel C Jankowitz, Jame Abraham, Antoinette R Tan, et al.
British Journal of Cancer
|
July 27, 2006
Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study
A W Blackstock, F Mornex, C Partensky, et al.
British Journal of Haematology
|
September 12, 2008
Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma
Sundar Jagannath, Bart Barlogie, James R Berenson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 11, 2008
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)
Richard J Gralla, Martin J Edelman, Frank C Detterbeck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study
M Martin, P Fumoleau, J A Dewar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial
Mark A Socinski, David E Morris, Jan S Halle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 2, 2008
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer
Frank C Detterbeck, Mark A Socinski, Richard J Gralla, et al.
British Journal of Haematology
|
October 6, 2004
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
S Jagannath, B Barlogie, J Berenson, et al.
Page
of 5